News
Imagine treating a genetic disease not by managing symptoms for life, but by correcting the underlying genetic error itself. Inventors at NIH are advancing that vision with a gene editing technology designed to deliver highly precise genetic corrections, opening new possibilities for therapies that
NIH has 1,200 scientists in the Intramural Research Program who research and develop new drugs, vaccines, methods, and other products to better public health. These scientists become inventors when their research results in a licensable material or product. The NIH Record chatted with two of them
The AUTM on the Air podcast has recently produced an episode featuring the NIH’s Dr. Mukul Ranjan discussing the origins of the Nagoya Protocol and its ongoing challenges, as well as the United States’ decision to not participate. The Nagoya Protocol is a supplement to the UN’s convention on
The Bayh-Dole Coalition has made all of the key documents in the Bayh-Dole legislation public and virtually accessible through a new online library. Previously, these documents were inaccessible and not housed together. Now, these documents have been compiled and annotated with the intent of